Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies R Bernardi, PP Pandolfi Nature reviews Molecular cell biology 8 (12), 1006-1016, 2007 | 1118 | 2007 |
Role of nucleophosmin in embryonic development and tumorigenesis S Grisendi, R Bernardi, M Rossi, K Cheng, L Khandker, K Manova, ... Nature 437 (7055), 147-153, 2005 | 711 | 2005 |
PML targeting eradicates quiescent leukaemia-initiating cells K Ito, R Bernardi, A Morotti, S Matsuoka, G Saglio, Y Ikeda, J Rosenblatt, ... Nature 453 (7198), 1072-1078, 2008 | 693 | 2008 |
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR R Bernardi, I Guernah, D Jin, S Grisendi, A Alimonti, J Teruya-Feldstein, ... Nature 442 (7104), 779-785, 2006 | 483 | 2006 |
PML regulates p53 stability by sequestering Mdm2 to the nucleolus R Bernardi, PP Scaglioni, S Bergmann, HF Horn, KH Vousden, ... Nature cell biology 6 (7), 665-672, 2004 | 448 | 2004 |
PML regulates apoptosis at endoplasmic reticulum by modulating calcium release C Giorgi, K Ito, HK Lin, C Santangelo, MR Wieckowski, M Lebiedzinska, ... Science 330 (6008), 1247-1251, 2010 | 432 | 2010 |
Loss of the tumor suppressor PML in human cancers of multiple histologic origins C Gurrieri, P Capodieci, R Bernardi, PP Scaglioni, K Nafa, LJ Rush, ... Journal of the National Cancer Institute 96 (4), 269-279, 2004 | 428 | 2004 |
Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction S Fumagalli, A Di Cara, A Neb-Gulati, F Natt, S Schwemberger, J Hall, ... Nature cell biology 11 (4), 501-508, 2009 | 384 | 2009 |
Role of PML and the PML-nuclear body in the control of programmed cell death R Bernardi, PP Pandolfi Oncogene 22 (56), 9048-9057, 2003 | 271 | 2003 |
Regulation of apoptosis by PML and the PML-NBs R Bernardi, A Papa, PP Pandolfi Oncogene 27 (48), 6299-6312, 2008 | 189 | 2008 |
Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase–mediated mTOR activation in tuberous sclerosis and human cancer LI Ma, J Teruya-Feldstein, P Bonner, R Bernardi, DN Franz, D Witte, ... Cancer research 67 (15), 7106-7112, 2007 | 166 | 2007 |
Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia D Magliulo, R Bernardi, S Messina Frontiers in oncology 8, 255, 2018 | 96 | 2018 |
Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation R Bernardi, DA Liebermann, B Hoffman Oncogene 19 (20), 2447-2454, 2000 | 92 | 2000 |
Multiparametric staining to identify apoptotic human cells C Negri, M Donzelli, R Bernardi, L Rossi, A Bürkle, AI Scovassi Experimental cell research 234 (1), 174-177, 1997 | 84 | 1997 |
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia C Gurrieri, K Nafa, T Merghoub, R Bernardi, P Capodieci, A Biondi, ... Blood 103 (6), 2358-2362, 2004 | 83 | 2004 |
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage P Salomoni, R Bernardi, S Bergmann, A Changou, S Tuttle, PP Pandolfi Blood 105 (9), 3686-3690, 2005 | 74 | 2005 |
The nucleolus: at the stem of immortality R Bernardi, PP Pandolfi Nature medicine 9 (1), 24-25, 2003 | 72 | 2003 |
The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence K Cheng, S Grisendi, JG Clohessy, S Majid, R Bernardi, P Sportoletti, ... Oncogene 26 (53), 7391-7400, 2007 | 71 | 2007 |
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment R Valsecchi, N Coltella, D Belloni, M Ponente, E Ten Hacken, C Scielzo, ... Blood, The Journal of the American Society of Hematology 127 (16), 1987-1997, 2016 | 68 | 2016 |
Hallmarks of triple negative breast cancer emerging at last? R Bernardi, L Gianni Cell research 24 (8), 904-905, 2014 | 65 | 2014 |